Latest BioAlps news
News
Inside TRB Chemedica: a visit to one of Valais’ quiet pharmaceutical powerhouses
Tucked away in Vouvry, in the Swiss canton of Valais, TRB Chemedica is the kind of company that rarely makes…
News
HAYA Therapeutics doses first cohort in Phase 1 trial of a precision therapy for cardiac fibrosis
Swiss-American biotech HAYA Therapeutics has dosed the first cohort in the Phase 1 clinical trial of HTX-001, its lead investigational…
News
Swiss Biotool Startup Bionomous Launches Sortivo
Swiss biotool startup Bionomous has launched Sortivo™, an automated benchtop platform for the gentle screening, sorting, and plating of complex…
News
Neurosoft Bioelectronics Closes $7.5M Oversubscribed Seed Round
Geneva-based neurotechlogy company Neurosoft Bioelectronics announces that it has raised a $7.5 million oversubscribed seed financing round. Headquartered in Campus…
News
The GenPK Project Receives CHF 3,5 millions from FNS
The Jules Gonin Eye Hospital, the CHUV and the University of Lausanne are to study the genomes of 12,000 people…
News
Investors & Innovators × JLABS Accelerator
On Wednesday, May 13th, at Campus Biotech Geneva, BioAlps welcomed Elena Fernandez Kleinlein and Michael Huebner of Johnson & Johnson…
News
Dr Andrea Pfeifer Retires From AC Immune
AC Immune SA, a Lausanne-based clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, announces that Dr Andrea Pfeifer has…
News
Robert Wenner Prize: Two Cancer Researchers Honoured
The Robert Wenner Prize, which recognises scientists in the field of cancer research, is being awarded this year for the…
News
Mindmaze joins forces with Vibra Healthcare to bring its neurotherapies to the United States
After first announcing a partnership in 2022, the Lausanne-based neurotech company aims to speed up the launch of its digital…
News
SDSC and Canton of Vaud Support Bewe Lab and Perivision
Bewe Lab and Perivision are among the four companies selected by Canton de Vaud and the Swiss Data Science Center…
News
Immitra Bio Receives a CHF 150,000 Gebert Rüf Stiftung InnoBooster Grant
Geneva-based startup Immitra Bio has been selected as one of the latest winners of the InnoBooster programme, supported by the…
News
HAS Healthcare Advanced Synthesis Group Announces Strategic Investments in Biodelphis Therapeutics
HAS Healthcare Advanced Synthesis (Ticino) and Biodelphis Therapeutics (Vaud) announced the signing of a strategic agreement to support the development…











